Literature DB >> 26167713

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel.

Thomas Bonnard1, Christoph E Hagemeyer2.   

Abstract

Severe thrombosis and its ischemic consequences such as myocardial infarction, pulmonary embolism and stroke are major worldwide health issues. The ferric chloride injury is now a well-established technique to rapidly and accurately induce the formation of thrombi in exposed veins or artery of small and large diameter. This model has played a key role in the study of the pathophysiology of thrombosis, in the discovery and validation of novel antithrombotic drugs and in the understanding of the mechanism of action of these new agents. Here, the implementation of this technique on a mesenteric vessel and carotid artery in mice is presented. The method describes how to label circulating leukocytes and platelets with a fluorescent dye and to observe, by intravital microscopy on the exposed mesentery, their accumulation at the injured vessel wall which leads to the formation of a thrombus. On the carotid artery, the occlusion caused by the clot formation is measured by monitoring the blood flow with a Doppler probe.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26167713      PMCID: PMC4544968          DOI: 10.3791/52838

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  34 in total

Review 1.  Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents.

Authors:  R J Leadley; L Chi; S S Rebello; A Gagnon
Journal:  J Pharmacol Toxicol Methods       Date:  2000 Mar-Apr       Impact factor: 1.950

2.  Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice.

Authors:  S Konstantinides; K Schäfer; T Thinnes; D J Loskutoff
Journal:  Circulation       Date:  2001-01-30       Impact factor: 29.690

Review 3.  The utility of animal models in the preclinical study of interventions to prevent human coronary artery restenosis: analysis and recommendations. On behalf of the Subcommittee on Animal, Cellular and Molecular Models of Thrombosis and Haemostasis of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.

Authors:  G J Johnson; T R Griggs; L Badimon
Journal:  Thromb Haemost       Date:  1999-05       Impact factor: 5.249

4.  Mechanisms underlying FeCl3-induced arterial thrombosis.

Authors:  A Eckly; B Hechler; M Freund; M Zerr; J-P Cazenave; F Lanza; P H Mangin; C Gachet
Journal:  J Thromb Haemost       Date:  2011-04       Impact factor: 5.824

Review 5.  Involvement of neutrophils in thrombus formation in living mice.

Authors:  R Darbousset; S Mezouar; F Dignat-George; L Panicot-Dubois; C Dubois
Journal:  Pathol Biol (Paris)       Date:  2014-01-31

6.  Murine thrombosis models.

Authors:  Sharlene M Day; Jennifer L Reeve; Daniel D Myers; William P Fay
Journal:  Thromb Haemost       Date:  2004-09       Impact factor: 5.249

7.  Antibody blockade or mutation of the fibrinogen gamma-chain C-terminus is more effective in inhibiting murine arterial thrombus formation than complete absence of fibrinogen.

Authors:  Markéta Jirousková; Igor Chereshnev; Heikki Väänänen; Jay L Degen; Barry S Coller
Journal:  Blood       Date:  2003-11-26       Impact factor: 22.113

8.  Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis.

Authors:  Xi Lei; Adili Reheman; Yan Hou; Hui Zhou; Yiming Wang; Alexandra H Marshall; Chaofan Liang; Xiangrong Dai; Benjamin Xiaoyi Li; Karen Vanhoorelbeke; Heyu Ni
Journal:  Thromb Haemost       Date:  2013-10-31       Impact factor: 5.249

9.  Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis.

Authors:  Yves Decrem; Géraldine Rath; Virginie Blasioli; Philippe Cauchie; Séverine Robert; Jérôme Beaufays; Jean-Marie Frère; Olivier Feron; Jean-Michel Dogné; Chantal Dessy; Luc Vanhamme; Edmond Godfroid
Journal:  J Exp Med       Date:  2009-10-05       Impact factor: 14.307

10.  Ferric chloride-induced murine carotid arterial injury: A model of redox pathology.

Authors:  Wei Li; Thomas M McIntyre; Roy L Silverstein
Journal:  Redox Biol       Date:  2013-01-26       Impact factor: 11.799

View more
  11 in total

1.  [Establishment of a rabbit model of small diameter vascular graft replacement].

Authors:  Jia-Qing Zhang; Kun-Tang Chen; Fu-Wei Zhang; Shao-Bin Li; Yuan-Zhou Wu; Jing Feng; Wu-Jun Wang; Yu-Sheng Yan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-05-20

2.  Ferric Chloride-induced Canine Carotid Artery Thrombosis: A Large Animal Model of Vascular Injury.

Authors:  Allyson L Huttinger; Debra G Wheeler; Surya Gnyawali; David Dornbos; Juliana M Layzer; Nicholas Venetos; Spencer Talentino; Nicholas J Musgrave; Cheyenne Jones; Camille Bratton; Matthew E Joseph; Chandan Sen; Bruce A Sullenger; Shahid M Nimjee
Journal:  J Vis Exp       Date:  2018-09-07       Impact factor: 1.355

3.  Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single-Chain Antibody Specific for Activated GPIIb/IIIa.

Authors:  Thomas Bonnard; Zachary Tennant; Be'Eri Niego; Ruchi Kanojia; Karen Alt; Shweta Jagdale; Lok Soon Law; Sheena Rigby; Robert Lindsay Medcalf; Karlheinz Peter; Christoph Eugen Hagemeyer
Journal:  J Am Heart Assoc       Date:  2017-02-03       Impact factor: 5.501

4.  HPW-RX40 prevents human platelet activation by attenuating cell surface protein disulfide isomerases.

Authors:  Po-Hsiung Kung; Pei-Wen Hsieh; Ying-Ting Lin; Jia-Hau Lee; I-Hua Chen; Chin-Chung Wu
Journal:  Redox Biol       Date:  2017-05-29       Impact factor: 11.799

5.  Iron deficiency-induced thrombocytosis increases thrombotic tendency in rats.

Authors:  Kristine Jimenez; Florentina Leitner; Aran Leitner; Gisela Scharbert; Philipp Schwabl; Anne-Margarethe Kramer; Anita Krnjic; Joachim Friske; Thomas Helbich; Rayko Evstatiev; Vineeta Khare; Christoph Gasche
Journal:  Haematologica       Date:  2021-03-01       Impact factor: 9.941

6.  Estimating dynamic vascular perfusion based on Er-based lanthanide nanoprobes with enhanced down-conversion emission beyond 1500 nm.

Authors:  Qian Jia; Zheng Li; Mingli Bai; Haohao Yan; Ruili Zhang; Yu Ji; Yanbin Feng; Zuo Yang; Zhongliang Wang; Jianxiong Li
Journal:  Theranostics       Date:  2021-10-11       Impact factor: 11.556

7.  Establishment of a Modified and Standardized Ferric Chloride-Induced Rat Carotid Artery Thrombosis Model.

Authors:  Xiao Lin; Peiqi Zhao; Zhongxiao Lin; Jiayu Chen; Lebohang Anesu Bingwa; Felix Siaw-Debrah; Peng Zhang; Kunlin Jin; Su Yang; Qichuan Zhuge
Journal:  ACS Omega       Date:  2022-03-02

Review 8.  Theranostic nanoparticles for the management of thrombosis.

Authors:  Peije Russell; Christoph Eugen Hagemeyer; Lars Esser; Nicolas Hans Voelcker
Journal:  Theranostics       Date:  2022-03-14       Impact factor: 11.600

Review 9.  Understanding the Pathophysiology of Thrombotic APS through Animal Models.

Authors:  Alex A Gandhi; Shanea K Estes; Christine E Rysenga; Jason S Knight
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

10.  Effect of Yiqi Huoxue Granules on Platelet Activation Induced by Thrombin.

Authors:  Zhen Lei; Shuibo Gao; Xinzhou Wang; Haixia Gao; Yongjun Han; Zhentao Wang; Hong Wu
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-16       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.